National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 6046 [2010-2560]
Download as PDF
<![CDATA[
6046
Federal Register / Vol. 75, No. 24 / Friday, February 5, 2010 / Notices
srobinson on DSKHWCL6B1PROD with NOTICES
Methodologies IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 3160, MSC 7770,
Bethesda, MD 20892. (301) 435–0695.
bentkn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business—Respiratory Sciences.
Date: March 11–12, 2010.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Ghenima Dirami, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892. 301–594–
1321. diramig@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Cell Biology.
Date: March 11, 2010.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
Contact Person: Alexandra M. Ainsztein,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5144,
MSC 7840, Bethesda, MD 20892. 301–451–
3848. ainsztea@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Fellowship:
Psychopathology, Developmental
Disabilities, Stress and Aging.
Date: March 12, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Cheri Wiggs, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3180,
MSC 7848, Bethesda, MD 20892. (301) 435–
1261. wiggsc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 29, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–2558 Filed 2–4–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
16:26 Feb 04, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Ancillary
Clinical Studies.
Date: February 16, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Suite 800, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Charles H Washabaugh,
PhD, Scientific Review Officer, Review
Branch, NIAMS/NIH, 6701 Democracy Blvd.,
Suite 800, Bethesda, MD 20892, (301) 594–
4952, washabac@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Career
Development, Research Training & Pathways
to Independence Review.
Date: March 1, 2010.
Time: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Charles H Washabaugh,
PhD, Scientific Review Officer, Review
Branch, NIAMS/NIH, 6701 Democracy Blvd.,
Suite 800, Bethesda, MD 20892, (301) 594–
4952, washabac@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
Dated: January 29, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–2560 Filed 2–4–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–3307–
EM; Docket ID FEMA–2010–0002]
Arizona; Emergency and Related
Determinations
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice.
SUMMARY: This is a notice of the
Presidential declaration of an
emergency for the State of Arizona
(FEMA–3307–EM), dated January 24,
2010 and related determinations.
DATES: Effective Date: January 24, 2010.
FOR FURTHER INFORMATION CONTACT:
Peggy Miller, Disaster Assistance
Directorate, Federal Emergency
Management Agency, 500 C Street, SW.,
Washington, DC 20472, (202) 646–3886.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that, in a letter dated
January 24, 2010, the President issued
an emergency declaration under the
authority of the Robert T. Stafford
Disaster Relief and Emergency
Assistance Act, 42 U.S.C. 5121–5207
(the Stafford Act), as follows:
I have determined that the emergency
conditions in certain areas of the State of
Arizona resulting from a severe winter storm
beginning on January 20, 2010, and
continuing, are of sufficient severity and
magnitude to warrant an emergency
declaration under the Robert T. Stafford
Disaster Relief and Emergency Assistance
Act, 42 U.S.C. 5121 et seq. (‘‘the Stafford
Act’’). Therefore, I declare that such an
emergency exists in the State of Arizona.
You are authorized to provide appropriate
assistance for required emergency measures,
authorized under Title V of the Stafford Act,
to save lives and to protect property and
public health and safety, and to lessen or
avert the threat of a catastrophe in the
designated areas. Specifically, you are
authorized to provide assistance for
emergency protective measures (Category B),
limited to direct Federal assistance, under
the Public Assistance program. This
assistance excludes regular time costs for
subgrantees’ regular employees.
Consistent with the requirement that
Federal assistance is supplemental, any
Federal funds provided under the Stafford
Act for Public Assistance will be limited to
E:\FR\FM\05FEN1.SGM
05FEN1
]]>Agencies
[Federal Register Volume 75, Number 24 (Friday, February 5, 2010)]
[Notices]
[Page 6046]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2560]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel, Ancillary
Clinical Studies.
Date: February 16, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Suite 800, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Charles H Washabaugh, PhD, Scientific Review
Officer, Review Branch, NIAMS/NIH, 6701 Democracy Blvd., Suite 800,
Bethesda, MD 20892, (301) 594-4952, washabac@mail.nih.gov.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel, Career
Development, Research Training & Pathways to Independence Review.
Date: March 1, 2010.
Time: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Charles H Washabaugh, PhD, Scientific Review
Officer, Review Branch, NIAMS/NIH, 6701 Democracy Blvd., Suite 800,
Bethesda, MD 20892, (301) 594-4952, washabac@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: January 29, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-2560 Filed 2-4-10; 8:45 am]
BILLING CODE 4140-01-P
